Document is current
Any future updates will be listed below
-
Authors
Azizova, Aynur
Prysiazhniuk, Yeva
Wamelink, Ivar J. H. G.
Cakmak, Marcus
Kaya, Elif
Wesseling, Pieter
de Witt Hamer, Philip C.
Verburg, Niels
Petr, Jan
Barkhof, Frederik
Keil, Vera C. https://orcid.org/0000-0001-8699-3506
-
Funding
Funding for this research was provided by:
Hanarth Fonds
- License Information
-
More Information
Article History
Received: 19 June 2024
Revised: 23 August 2024
Accepted: 22 September 2024
First Online: 19 October 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Vera C. Keil.
: The authors of this manuscript declare relationships with the following companies: V.C.K.: Lilly Pharma (Consulting); Junior Deputy Editor for European Radiology, as such they did not participate in the selection or review processes for this article. The remaining authors declare no conflicts of interest.
: One of the authors has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: The same study cohort was used in another study, which was recently accepted by the Journal of Neuroimaging on August 14, 2024. The in-press study explored a different research question focused on predicting glioma enhancement features using the proposed Enhancement Prediction Decision Tree.
:
